The Food and Drug Administration (FDA) has approved Romvimza ™ (vimseltinib) for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will ...

The following is a summary of “Prophylaxis for renal patients at risk of COVID-19 infection: results from the intranasal niclosamide randomised, double blinded, placebo controlled arm of the PROTECT-V ...

The need to treat asymptomatic or minimally symptomatic disease has remained controversial in diagnosed disease. Even less ...

A new study finds that U.S. youths with symptomatic ADHD are significantly more likely to initiate e-cigarette and tobacco ...

Football hooliganism is back in the headlines with the cabinet approving a new bill allowing the government to take “decisive” action, including banning away fans from football matches.The recent ...

Despite advances in its management, current treatment provides no cure and many patients remain symptomatic. For many years, nitrates, ß-blockers and calcium antagonists have been the treatments ...

The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of noncancerous tumors on ...

Adult and pediatric patients with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas that are not amenable ...